*ST Huicheng: Restructuring investor Zhi En Biotechnology subscribes for 258 million shares of the company, holding a 20.04% stake

*ST Huicheng Announcement: The company has signed a Supplementary Agreement to the Restructuring Investment Agreement with restructuring investor Zhen En Biotechnology. According to the agreement, Zhen En Biotechnology will subscribe for 26.05M shares of the company’s bonus shares at a price of 2.01 yuan per share, with a capital contribution of 52.4475 million yuan, maintaining a shareholding ratio of 20.04%. The company’s total share capital will increase to 26.05M shares. This restructuring aims to optimize the company’s asset-liability structure, resolve debt risks, and restore and enhance the company’s sustainable operation and profitability.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin